Fed. Circ. Tosses Becton's $58M Syringe Patent Win
In a 2-1 decision, the U.S. Court of Appeals for the Federal Circuit reversed the ruling in Becton's favor that found Covidien's Monoject Magellan syringes infringed a patent.
The U.S. District Court for the District of Delaware incorrectly construed the “spring means” limitation of the asserted claims and erred in denying a...
To view the full article, register now.